Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Jul 2025 for Inozyme Pharma, Inc., €1.4M.
Filing timeline
BuySaleAxel Bolte
Insider track record
Disclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Axel Bolte: trading record in brief
Axel Bolte (chief executive) discloses dealings in 2 companies, chiefly Inozyme Pharma, Inc. and IVERIC bio, Inc. In total, 13 filings cover trades dated from 3 June 2016 to 1 July 2025.
On the open market, the record shows 2 purchases worth €410k and 2 sales worth €27k. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 5 option exercises.
The latest filing, published on 3 July 2025, reports a transaction of €1.4M in Inozyme Pharma, Inc. The clock since the last published purchase (20 April 2022) now reads 1,648 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Axel Bolte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
423,926 shares@ US$4.0076.6% of flowCommon StockSEC:0000950170-25-094096:0
152,823 shares@ US$0.9827.2% of flowCommon StockSEC:0000950170-25-075148:0
22,088 sharesCommon StockSEC:0001104659-23-080679:0
14,588 sharesCommon StockSEC:0001410939-23-000077:0
4,806 shares@ US$2.212.0% of flowCommon StockSEC:0001209191-23-022467:0
3,315 shares@ US$2.281.6% of flowCommon StockSEC:0001209191-22-052023:0
7,500 sharesCommon StockSEC:0001410939-22-000069:0
67,750 shares@ US$3.6912.4% of flowCommon StockSEC:0001209191-22-024917:0
Canonical exit: 18 Jul 2022 (T+90)
66,788 shares@ US$0.982.9% of flowCommon StockSEC:0001209191-21-043205:0
9 of 9 declarations
